glp-1 news today 2025 A network meta-analysis backed weight-loss benefits with several receptor agonists, with less certainty for newer-generation agents. Read more at the link in bio GLP-1 Pipeline Update: August 2025

Objective To determine whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with an increased risk of suicidal ideation, self-harm, and suicide among patients with type 2 diabetes compared with the use of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter-2 (SGLT-2) inhibitors

The recent uptick and rise in popularity of GLP-1 drugs for addressing weight loss and obesity has led to an increase in U.S

This review focuses on how GLP-1RAs impact lipid-related outcomes

Similar to other diabetes drugs, metformin and Ozempic are used for managing blood sugar levels

I ordered GLP-1s from Noom, reviewed the program myself, and scored it 69/100

Ask your care team about trials: if youre eligible for a cognitive-risk study, you might consider participating